Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Kromek Group plc ( (GB:KMK) ) just unveiled an update.
Kromek Group plc reported that its non-executive chairman, Rakesh Sharma, has increased his personal stake in the company by purchasing 102,669 ordinary shares at 9.74p each. Following this transaction, Sharma now holds 1,310,208 shares, representing approximately 0.2% of Kromek’s issued share capital.
The chairman’s additional investment signals board-level confidence in Kromek’s prospects as it pursues growth in advanced imaging and CBRN detection markets. The move may be viewed positively by investors, reinforcing alignment between leadership and shareholders at a time when the company is commercialising its radiation and bio-detection technologies.
The most recent analyst rating on (GB:KMK) stock is a Buy with a £12.50 price target. To see the full list of analyst forecasts on Kromek Group plc stock, see the GB:KMK Stock Forecast page.
Spark’s Take on GB:KMK Stock
According to Spark, TipRanks’ AI Analyst, GB:KMK is a Outperform.
The score is driven primarily by improved financial performance (strong revenue growth, expanding margins, and low leverage), tempered by mixed free cash flow trends. Technicals are supportive due to a strong uptrend and positive MACD, but overbought RSI/Stoch readings add pullback risk. Valuation is moderate on a 20.508 P/E with no dividend yield.
To see Spark’s full report on GB:KMK stock, click here.
More about Kromek Group plc
Kromek Group plc is a UK-headquartered detection technology specialist focused on advanced imaging and CBRN (chemical, biological, radiological and nuclear) detection. The company develops radiation and bio-detection solutions for medical CT and SPECT imaging, security and industrial markets, and supplies CZT-based detector components to OEMs worldwide.
In the CBRN segment, Kromek provides compact, handheld nuclear radiation detectors used to protect infrastructure, events and urban environments from threats such as dirty bombs. It is also developing autonomous bio-security systems for airborne pathogen detection and is listed on London’s AIM market under the ticker KMK.
Average Trading Volume: 3,491,135
Technical Sentiment Signal: Buy
Current Market Cap: £70.42M
For an in-depth examination of KMK stock, go to TipRanks’ Overview page.